Lexington, MA, – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued a patent, number US8,409,807 (the ‘807 patent), covering T2Candida®, the Company’s flagship diagnostic test. T2Candida identifies sepsis-causing Candida species directly from whole blood at ~1CFU/mL sensitivity in approximately three hours compared […]
Nashville, Tenn.– Insight Genetics, which has developed a diagnostic test that can more accurately determine if certain lung cancer patients will respond to targeted therapies, has been selected by the National Cancer Institute (NCI) to participate in the Clinical Assay Development Program (CADP). The CADP is an initiative of NCI’s Division of Cancer Treatment and […]
Austin, Texas – Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). CPRIT was established to expedite innovation and commercialization in the area of cancer research and […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has been recognized by Forbes as one of America’s 100 Most Trustworthy Companies. The list is selected following a comprehensive evaluation of governance and accounting practices of candidate companies having market capitalization over $250 million. The rankings are based on data from GMI Ratings […]
CAMBRIDGE, Mass., — GenoSpace, LLC, a company that builds information systems capable of storing and integrating genomic information and other health data for clinical care and advanced research, today announced the addition of Daniel Meyer as Chief Financial Officer. “We have been working with Dan in an advisory relationship since forming the company, and are […]
SAN DIEGO,– Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Matt Posard to its Board of Directors. Mr. Posard is currently Senior Vice President and General Manager of Translational & Consumer Genomics at Illumina, Inc. “We welcome Matt to our Board of Directors. His strategic marketing experience will complement Halozyme’s Board well as […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announces plans to invest $18 million in a multi-phase plan to expand its facility in Pleasanton, Calif., where it will implement Current Good Manufacturing Practice (cGMP) capabilities for its genetic analysis products. The project, which executes against Life’s roadmap to broaden its offerings in the growing […]
SAN DIEGO, — Trovagene, Inc. (NASDAQ: TROV), today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus (HPV) test. The non-invasive test is designed to accurately identify the presence or absence of 15 known high-risk HPV strains using proprietary DNA sequences. Approximately 20 million Americans carry HPV, with six million […]
SHANGHAI, — Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by China’s State Food and Drug Administration (SFDA) for clinical diagnostic use in China and the launch of 10 Assays from its joint venture with Daan Gene. The development marks a major extension of Life […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the first drug to be offered in the just-launched BD Simplist™ ready-to-administer, line of prefilled generic injectables. BD Simplist prefilled injectables will be commercialized and manufactured by […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
